Immunology

C.J. McMahan, J.L. Slack, B. Mosley, D. Cosman, et al., "A novel IL-1 receptor, cloned from B-cells by mammalian expression, is expressed in many cell types," The EMBO Journal, 10:2821-32, 1991. John E. Sims (Immunex Research and Development Corp., Seattle): "Interleukin-1 is a central mediator of inflammatory responses, and it has significant immune and hematopoietic effects, as well. For these reasons, it is highly desirable to understand its mechanisms of action and, hopefully, to discover

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

C.J. McMahan, J.L. Slack, B. Mosley, D. Cosman, et al., "A novel IL-1 receptor, cloned from B-cells by mammalian expression, is expressed in many cell types," The EMBO Journal, 10:2821-32, 1991.

John E. Sims (Immunex Research and Development Corp., Seattle): "Interleukin-1 is a central mediator of inflammatory responses, and it has significant immune and hematopoietic effects, as well. For these reasons, it is highly desirable to understand its mechanisms of action and, hopefully, to discover ways of regulating its activity. With this aim, several years ago we cloned an interleukin-1 receptor, now known as the type I receptor. At the time, that was the only IL-1 receptor known, but the subsequent availability of cDNA probes and antibodies to the type I receptor revealed the existence of a second IL-1 receptor, which we called the type II receptor; it is described in this paper.

"I think the work reported has been ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies